{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "ANTENATAL MANAGEMENT OF PRE-ECLAMPSIA AND HYPERTENSION"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "11006"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, Obstetricians and Paediatricians"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "23 September 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "22 September 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NICE Guidance NG133 Hypertension in Pregnancy"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Miss Dutta, Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Maternity and Gynaecology Practice Steering Group"
                    },
                    {
                        "text": "8th September 2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Thakur, Clinical Director"
                    },
                    {
                        "text": "8th September 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "22 September 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "October 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2612 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Miss Thakur"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Mr Gangooly"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Mr Partington"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Miss Sharma"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Mr Fiadjoe"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Miss Joshi"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Miss Kausar"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Amanda Dixon"
                    },
                    {
                        "text": "Labour Ward Manager, Lead Midwife for Acute Inpatient Services"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Bernie O'Sullivan"
                    },
                    {
                        "text": "Team leader for Day Assessment Unit"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Angela Woolfenden"
                    },
                    {
                        "text": "Lead Midwife for Community Services"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Carole Hughes"
                    },
                    {
                        "text": "Team Leader for Community Midwives"
                    },
                    {
                        "text": "12 August 2020"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "10September 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Standard Infection Prevention 04072 Hand Hygiene 06036 Maternity Record Keeping including Documentation in Handheld Records 05110 Management of eclampsia and severe pre-eclampsia 06033 Referral and Care of Women on The Antenatal Assessment and Treatment Unit 07043 Abdominal palpation and examination in pregnancy 06034 Reduced Fetal Movements"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 10,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Sue Alcide"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Oct 2011"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Clarification to point 6.2"
                    },
                    {
                        "text": "Dec 2012"
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "Anita Rao"
                    },
                    {
                        "text": "Clarification to 10.1"
                    },
                    {
                        "text": "Feb 2014"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Madhu Joshi"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Oct 2014"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Madhu Joshi"
                    },
                    {
                        "text": "Clarification to point 9.3; bullet point 4"
                    },
                    {
                        "text": "14 December 2015"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Anita Dutta"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "07 November 2017"
                    },
                    {
                        "text": "3.1"
                    },
                    {
                        "text": "Chris Berner"
                    },
                    {
                        "text": "Amendment to points 8.1, 8.3 and new Appendix C"
                    },
                    {
                        "text": "26 February 2020"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Full review: amendments to points 4.0, 6.1, 11.2, 12.2.2, 12.3.2, 14.0, 15.0, 15.3, 15.5, 16.0, 16.1, 18.4, 20.1, 22.2, 23.0, 27.0"
                    },
                    {
                        "text": "23 September 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment ..................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Rationale for Examination of the Placenta ............................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust .................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Background ................................................................................................................. 4 6 Definitions................................................................................................................5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Antenatal Care and General Aspects.......................................................................5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Symptoms and Signs of Pre-eclampsia.....................................................................5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Antiplatelet Agents....................................................................................................5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Assessment in the Day Assessment Unit (DAU)......................................................7 11 Assessment of Proteinuria in Hypertensive Disorders of Pregnancy....................7 12 Management of Different Hypertensive Disorders...................................................8 13 Fetal Monitoring...........................................................................................................9 14 Corticosteroids for Fetal Lung Maturation ............................................................... 9 15 Role of the DAU Midwife in Relation to Hypertension..............................................9 16 Role of the DAU Midwife in Relation to Moderate/Severe Hypertension..............10 17 Blood Tests Relating to Pre-eclampsia ................................................................... 10 18 Laboratory Tests for Proteinuria ............................................................................. 10 19 Umbilical Artery Doppler .......................................................................................... 10 20 DAU Obstetric Review...............................................................................................12 21 Allocation to a Named Consultant...........................................................................13 22 Follow-up Monitoring on the Day Assessment Unit and Community Setting....13"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Staffing and Training.................................................................................................14 24 Professional Midwifery Advocates..........................................................................15 25 Infection Prevention..................................................................................................16 26 Audit and Monitoring.................................................................................................15"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 0.21,
                "text": "Approval and Implementation..................................................................................16 28 References..................................................................................................................19 Appendix A: Hypertension/Pre Eclampsia Flow charts.................................................Appendix B: Antenatal Pharmacological Management..................................................25 Appendix C: GP Letter for prescription of Aspirin..........................................................26 Appendix D: Management of Hypertension Visual Summary........................................27 Appendix E: Preliminary Equality Analysis.....................................................................28"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "To ensure a system of clear referral pathways are established, so that pregnant patients who require additional care are managed and treated by the appropriate specialist team when problems are identified."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "To set clear definitions of pregnant patients who will be appropriate for referral/ admission."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "To provide an individualised service, during assessment, treatment or admission. Antenatal care should be readily and easily accessible to all patients and should be sensitive to the needs of the individual patient and local community."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid and South Essex NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 1,
                "text": "(Refer to Appendix E)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Incidence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Maternal deaths from hypertensive disorders are at their lowest ever rate, with fewer than one death for every million women giving birth. This represents a major success for research, audit and evidence-based guidelines leading to improvements in care. (MBRRACE-UK 2015-17)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "The Specialist Nurse for Guidelines and Audit is responsible for ensuring  clinical policies, guidelines and SOPs are evidence-based and developed in line with national guidelines and following appropriate consultation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The clinical director is responsible for the implementation of this guideline within the directorate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The Head of Midwifery, maternity matrons and maternity managers are responsible for ensuring maternity staff are aware of the guideline and implement it."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The Obstetric Clinical Lead Consultant and Labour Ward Lead Consultant are responsible for ensuring the implementation of this guideline within the clinical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "All maternity staff are responsible for ensuring they are familiar with this guideline in relation to their practice and have the appropriate skills to implement this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Background"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "Hypertension is the most common first sign of pre-eclampsia. In the most recent UK perinatal mortality report, 1 in  (5%) stillbirths in infants without congenital abnormality occurred in women with pre-eclampsia. Pre-eclampsia is also associated with fetal growth restriction, low birth weight, preterm delivery, small for gestational age (SGA) infants and respiratory distress syndrome (The Magpie Collaborative Group, 2007). 8\u2013 10% of all preterm births result from hypertensive disorders. Preterm delivery occurs in half of women with severe pre-eclampsia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "New hypertension can occur without significant proteinuria (gestational hypertension) or with significant proteinuria (pre- eclampsia)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Hypertensive disorders during pregnancy can occur in women with chronic hypertension, (pre existing hypertension)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Treatment and care should take into account women's individual needs and preferences. Good communication is essential supported by evidence based information, to allow women to reach informed decisions about their care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Definitions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Degrees of hypertension:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "Hypertension \u2013140/90-159/109"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "Severe Hypertension - >160/110"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "New hypertension - hypertension at or after 20 weeks gestation in a patient with a diastolic blood pressure of less than 90mmHg before 20 weeks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "Gestational hypertension or Pregnancy induced hypertension - new hypertension presenting after  weeks without significant proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 1,
                "text": "Chronic hypertension - a diastolic blood pressure pre-pregnancy or at booking (before 20 weeks) of 90mmHg or more or that is being treated at the time of referral to maternity services"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Degrees of proteinuria:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "New proteinuria - the presence of proteinuria as shown by 1+ (0.3g/l) or more on proteinuria dipstick testing o or a urine protein excretion of 300mg or more per  hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Significant proteinuria - urine protein excretion \u2265 300mg per  hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Definitions of hypertension:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "Pre-eclampsia - new hypertension and significant proteinuria at or after  weeks of pregnancy, confirmed if it resolves after delivery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Superimposed pre-eclampsia - the development of features of pre-eclampsia in the context of existing hypertension, existing proteinuria or both"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Severe pre- eclampsia. Pre- eclampsia with severe hypertension and/or with symptoms, and/or biochemical and/or haematological impairment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "text": "Eclampsia Convulsive condition associated with pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Antenatal Care and General Aspects"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "As part of routine antenatal care all women in their first ongoing pregnancy should be reviewed (including BP measurement, urine dipstick and pre-eclampsia symptoms/signs assessment) every 3-4 weeks from  weeks gestation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the guideline entitled \u2018Maternity Care'; register number 04272)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Symptoms and Signs of Pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Pregnant women should be made aware of the need to seek immediate advice from a healthcare professional if they experience symptoms of pre-eclampsia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Symptoms include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "Headache"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "Visual disturbances, such as blurring or flashing lights before the eyes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "Epigastric pain or right upper quadrant (RUQ) pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "Nausea or vomiting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "text": "Sudden swelling of the face, hands or feet"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 1,
                "text": "Decreased fetal movements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Signs include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "Raised BP and proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "Oedema (facial in particular)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "text": "Clonus (>3 beats is significant)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "Liver edge or epigastric tenderness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "Papilloedema"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "Blood tests abnormalities (haemolysis, alterations of liver function tests, decreased platelets, increased creatinine, increased urate)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Antiplatelet Agents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Advise women at high risk of pre-eclampsia to take 150 mg of aspirin daily from  weeks until the birth of the baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 1,
                "prefix": 9.2,
                "text": "Women at high risk are those with any of the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "text": "Hypertensive disease during a previous pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "Chronic kidney disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "Autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "Type 1 or type 2 diabetes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "Pre-existing hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "Sickle cell disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "PAPP-A < 0.3 MoM"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Advise women with more than one moderate risk factor for pre-eclampsia to take 150 mg of aspirin daily from  weeks until the birth of the baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 1,
                "prefix": 9.4,
                "text": "Factors indicating moderate risk are:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "First pregnancy age > 40 years"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Pregnancy interval of more than  years"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "Body mass index (BMI) of 35 kg/m2 or more at first visit"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "text": "Family history of pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "Multiple pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Assessment in the Day Assessment Unit (DAU)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix A)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Maternal and fetal assessment to be undertaken within 30 minutes of admission to unit; once the woman has been shown to her bed or assessment area."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Large cuffs must be used for patients with an arm circumference of 41cm or more. Use equipment that is accurate in measuring hypertensive individuals; automated devices that are accurate in pregnancy can under-read by clinically significant amounts in patients with pre-eclampsia. The most accurate is the standard mercury  sphygmomanometer. The environment should be relaxed, quiet and preferably after rest."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Clinical assessment by the midwife should be consistent and documented as follows in the patient's healthcare records:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Review of current obstetric history - note the most recent community dipstick test result and date; gestational age; booking blood pressure; booking dipstick protein results; booking risk factors"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "Clinical assessment of maternal symptoms relating to pre-eclampsia \u2013 visual disturbance (\u2018tunnelling'), headaches, nausea, epigastric pain/ right upper quadrant pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "Clinical assessment of fetal size and wellbeing relating to pre-eclampsia. This generally includes measurement of symphysis -fundal height and clinical enquiry about fetal movements. (Refer to the guideline entitled \u2018Abdominal palpation and examination in pregnancy' register number 07043; and the guideline entitled \u2018Reduced fetal movements', register number 06034)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "If there are no concerns regarding the fetal movements and the fetal growth is normal (and no other concerns in relation to the fetus) routinely a CTG is not required. However, if a CTG is required, it should be undertaken for women who are more than equal to 28 weeks gestation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Dipstick test for proteinuria - dipstick proteinuria (none, trace, 1+, 2+, >2+ protein)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Obtain PET bloods"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "Obstetric review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Assessment of Proteinuria in Hypertensive Disorders of Pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Use urine dipstick or a spot urinary protein: creatinine ratio (PCR) for estimating proteinuria."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "text": "Perform midstream specimen of urine (MSU) to exclude infection (if leucocytes and/or nitrite +)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "If dipstick urinalysis of 1+ proteinuria is obtained use a spot urinary PCR to quantify the proteinuria."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "If proteinuria is confirmed without hypertension the patient should be referred to the linked consultant for assessment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Use of PCR as a diagnostic test for PET"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Urinary PCR greater than 30 mg/mmol is diagnostic of PET and no further testing is required"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "If the protein creatinine ratio is between 30-49 mg/mmol proceed to a 24-hour urine collection, if this is greater than 300 mg protein in  hours it is diagnostic of PET."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "If the urine volume on  hour collection is less than a litre, this may result in a false negative for proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Consultant at any time may decide to proceed to a  hour urine collection"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "text": "There is no need to repeat quantification of proteinuria once pre-eclampsia is proven."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Adequate blood pressure control, normal PET bloods and asymptomatic for PET then a  hour urine collection if required may be carried out as an outpatient (i.e. PCR is 30-49mg/mmol)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Management of Different Hypertensive Disorders"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "prefix": 12.1,
                "text": "Pre-existing Hypertension/Chronic Hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "12.1.1 Antenatal Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "Women who have had hypertension diagnosed prior to (or in early) pregnancy should be referred to their lead obstetric consultant by  weeks gestation. (Refer to appendix for pharmacological management for details on treatment)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "In women taking ACE inhibitors or ARBs or diuretics stop antihypertensive treatment pre-pregnancy if possible or when they become pregnant and offer alternatives if blood pressure remains > 150/100 mmHg."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "In pregnant women with uncomplicated essential hypertension aim to keep blood pressure lower than 150/100 mmHg. Do not offer treatment to lower diastolic pressure below 80mmHg in these patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "text": "If the blood pressure is satisfactory without treatment the woman should be counselled that antihypertensive medication may be required at 26-30 weeks gestation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "Offer pregnant women with target-organ damage secondary to chronic hypertension (for example, kidney disease) treatment with the aim of keeping blood pressure lower than 140/90 mmHg."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "Schedule additional antenatal consultations based on the individual needs of the woman and her baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "12.1.2 Timing of Birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 37.0,
                "text": "Do not plan delivery before  weeks in women with pre-existing hypertension whose blood pressure is lower than 160/110 mmHg, with or without antihypertensive treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 37.0,
                "text": "After  weeks, timing of birth and maternal and fetal indications for birth should be agreed between the woman and the link-obstetrician/ obstetric medicine team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "text": "If the blood pressure is well controlled, there is no superimposed PET and the fetal growth is normal, then pre-existing hypertension per se is not an indication for induction."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 1,
                "prefix": 12.2,
                "text": "Management of Pregnancy Induced Hypertension (PIH)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "12.2.1 Antenatal Care"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "prefix": 48.0,
                "text": "Initial assessment of women with PIH should be carried out in DAU or in their link consultant clinic within  hours (unless sever which should be reviewed that day)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "In women receiving outpatient care for severe PIH, after it has been effectively controlled, measure blood pressure and test urine twice weekly and carry out weekly blood tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "prefix": 32.0,
                "text": "In women with mild or moderate hypertension presenting before  weeks, or at high risk of pre-eclampsia, measure blood pressure and test urine twice weekly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "12.2.2 Table  Management of Pregnancy Induced Hypertension"
            }
        },
        {
            "type": "table",
            "sequence_num": 133,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Degree of Hypertension"
                    },
                    {
                        "text": "Hypertension (140/90-159/109 mmHg)"
                    },
                    {
                        "text": "Sever Hypertension (160/110mmHg or higher)"
                    },
                    {
                        "text": "Admit to Hospital"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "Yes (until blood pressure is 159/109 mmHg or less)"
                    },
                    {
                        "text": "Treatment"
                    },
                    {
                        "text": "With first line drug therapy to keep: Diastolic BP between 80-100mmHg Systolic BP less than 150 mmHg Offer pharmacological treatment if BP remains above 140/90 mmHg Aim for BP of 135/85 mmHg or less"
                    },
                    {
                        "text": "With first line drug therapy to keep: Diastolic BP between 80-100mmHg Systolic BP less than 150mmHg Offer pharmacological treatment to all women. Aim for BP of 135/85 mmHg or less"
                    },
                    {
                        "text": "Measure Blood Pressure"
                    },
                    {
                        "text": "At least twice a week until BP is 135/85 mmHg or less"
                    },
                    {
                        "text": "Every 15-30 minutes until BP is less than 160/110 mmHg Then at least four times a day"
                    },
                    {
                        "text": "Test for Proteinuria"
                    },
                    {
                        "text": "At each visit a urinalysis dipstick"
                    },
                    {
                        "text": "Daily urinalysis dipstick"
                    },
                    {
                        "text": "Blood tests"
                    },
                    {
                        "text": "PET Blood tests at presentation and then weekly"
                    },
                    {
                        "text": "PET blood tests Test at presentation and then twice weekly"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 134,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Do not carry out further blood tests if no proteinuria at subsequent visits"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Fetal assessment"
                    },
                    {
                        "text": "Offer fetal heart auscultation at every antenatal appointment. Carry out a CTG only if clinically indicated"
                    },
                    {
                        "text": "Offer fetal heart auscultation at every antenatal appointment Carry out ultrasound assessment of the fetus at diagnosis and, if normal, repeat every 2 weeks, if severe hypertension persists Carry out a CTG at diagnosis and then only if clinically indicated"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "text": "."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "text": "12.2.3 Timing of Birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "text": "Follow the same recommendations as described for pre-existing hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 1,
                "prefix": 12.3,
                "text": "Management of pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "text": "12.3.1 Treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "text": "If PET confirmed admit the woman (usually until delivery)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "text": "The rationale for admitting women with a diagnosis of pre-eclampsia is the increased risk of placental abruption and eclampsia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "On admission, any symptom relating or possibly relating to pre-eclampsia (headache, abdominal pain, breathlessness) should prompt consideration of a full set of observations (temperature, pulse, respiratory rate, blood pressure), PET bloods, and medical review."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "text": "12.3.2 Table 2. Management of pregnancy with pre-eclampsia"
            }
        },
        {
            "type": "table",
            "sequence_num": 144,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Degree of Hypertension"
                    },
                    {
                        "text": "Hypertension (140/90-159/109 mmHg)"
                    },
                    {
                        "text": "Severe Hypertension (160/110 mmHg or higher)"
                    },
                    {
                        "text": "Admit to Hospital"
                    },
                    {
                        "text": "Yes Admit if any clinical concerns for the wellbeing of the woman or baby"
                    },
                    {
                        "text": "Yes Admit, but if BP falls below 160/110 mmHg then manage as for hypertension"
                    },
                    {
                        "text": "Treatment"
                    },
                    {
                        "text": "With first line drug therapy to keep: Diastolic BP between 80-100 mmHg Systolic BP less than 150 mmHg Offer pharmacological treatment if BP remains above 140/90 mmHg"
                    },
                    {
                        "text": "With first line drug therapy to keep: Diastolic BP between 80-100Hg Systolic BP less than 150 mmHg Offer pharmacological treatment to all women Aim for BP of 135/85 mmHg or less"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 145,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Aim for BP of 135/85 mmHg or less"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Measure Blood Pressure"
                    },
                    {
                        "text": "At least four times a day At least every 48 hours, and more frequently if the woman is admitted to hospital"
                    },
                    {
                        "text": "More than four times a day depending upon clinical circumstances Every 15\u201330 minutes until BP is less than 160/110 mmHg, then at least 4 times daily while the woman is an inpatient, depending on clinical circumstances"
                    },
                    {
                        "text": "Test for Proteinuria"
                    },
                    {
                        "text": "Daily dipstick urine (Do not repeat quantification of proteinuria)"
                    },
                    {
                        "text": "Daily dipstick urine (Do not repeat quantification of proteinuria)"
                    },
                    {
                        "text": "Blood Tests"
                    },
                    {
                        "text": "PET Bloods Test at presentation and then three times weekly"
                    },
                    {
                        "text": "PET Bloods Test at presentation and then three times weekly/ daily at consultant's discretion"
                    },
                    {
                        "text": "Fetal assessment"
                    },
                    {
                        "text": "Offer fetal heart auscultation at every antenatal appointment Carry out ultrasound assessment of the fetus at diagnosis and, if normal, repeat every 2 weeks Carry out a CTG at diagnosis and then only if clinically indicated"
                    },
                    {
                        "text": "Offer fetal heart auscultation at every antenatal appointment Carry out ultrasound assessment of the fetus at diagnosis and, if normal, repeat every 2 weeks Carry out a CTG at diagnosis and then only if clinically indicated"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "text": "12.3.3 Timing of birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Initial stabilization of the maternal condition leads to a safer delivery by whatever route."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "Check to see if the patient fits the criteria for inclusion in the Severe PET Protocol."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "text": "Consultant obstetric staff should document in the woman's notes the maternal"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "(biochemical, haematological and clinical) and fetal thresholds for elective birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "prefix": 34.0,
                "text": "before  weeks in women with pre-eclampsia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "Possible criteria for intervention:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "Fetal indications:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "Maternal indications"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "Creatinine > 120 \u03bcmol/L"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Inability to control SBP<160mmHg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 1,
                "text": "Recommend birth within 24\u201348 hours for women who have pre-eclampsia at 38 weeks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Fetal Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 1,
                "prefix": 13.1,
                "text": "Women at High Risk of Pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Carry out uterine artery Doppler between  and  weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "text": "Carry out ultrasound fetal growth and amniotic fluid volume assessment and umbilical artery Doppler velocimetry starting at 28-30 weeks (or at least 2 weeks before previous gestational age of onset if earlier than 28 weeks) and repeating 4 weeks later in women with previous:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "text": "Severe pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "prefix": 34.0,
                "text": "Pre-eclampsia that needed birth before  weeks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "text": "Pre-eclampsia with a baby whose birth weight was < 10th centile"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "text": "Intrauterine death"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "text": "Placental abruption"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 1,
                "prefix": 13.2,
                "text": "Pre-existing hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "13.2.1 Carry out uterine artery Doppler between  and  weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "prefix": 34.0,
                "text": "13.2.2 Carry out ultrasound fetal growth and amniotic fluid volume assessment and umbilical artery Doppler velocimetry 28-30 weeks and 32-34 weeks. If results are normal, do not repeat at more than  weeks, unless otherwise clinically indicated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 0,
                "text": "13.2.3 Only carry out CTG if fetal activity is abnormal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 1,
                "prefix": 13.3,
                "text": "Mild and moderate PIH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "prefix": 34.0,
                "text": "13.3.1 In women with mild or moderate gestational hypertension, carry out ultrasound fetal growth and amniotic fluid volume assessment and umbilical artery Doppler velocimetry if diagnosis is confirmed at less than  weeks (do not perform these tests if diagnosis is confirmed beyond  weeks). If results are normal, do not repeat at more than  weeks, unless otherwise clinically indicated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "text": "13.3.2 Only carry out CTG if fetal activity is abnormal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 1,
                "prefix": 13.4,
                "text": "Severe PIH or pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "13.4.1 If conservative management is planned, carry out ultrasound fetal growth and amniotic fluid volume assessment and umbilical artery Doppler velocimetry at diagnosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "Repeat them every 2 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "If the umbilical Doppler is above the normal range repeat weekly if end diastolic flow present and twice weekly if absent"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "text": "13.4.2 Carry out CTG at diagnosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 0,
                "text": "If the results of all fetal monitoring are normal do not routinely repeat CTG more than weekly, unless any of the following occur:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 180,
            "data": {
                "is_heading": 0,
                "text": "The woman reports a change in fetal movement"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 0,
                "text": "Vaginal bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 0,
                "text": "Abdominal pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 0,
                "text": "Deterioration in maternal condition."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 0,
                "text": "13.4.3 Document a care plan that includes all of the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 0,
                "text": "The timing and nature of future fetal monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 0,
                "text": "Fetal indications for birth and if and when corticosteroids should be given when discussion with neonatal paediatricians and obstetric anaesthetists should take place and what decisions should be made."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Corticosteroids for Fetal Lung Maturation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 188,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "If birth is considered likely within 7 days in women with pre-eclampsia:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "in women between  and  weeks give two doses of betamethasone  mg intramuscularly  hours apart"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "Consider the same treatment in women between 34 and 36+6 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Role of the DAU Midwife in Relation to Hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 192,
            "data": {
                "is_heading": 1,
                "text": "(Refer to Appendix A)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "The DAU midwife should undertake the following action in relation to mild hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "New proteinuria without hypertension \u2013 if there is no clinical suspicion of fetal compromise, no maternal symptoms but there is 1+ of proteinuria on the dipstick the following should be performed:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 0,
                "text": "No significant proteinuria \u2013 contact the community lead to arrange the next pre- eclampsia assessment in the community within one week"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 196,
            "data": {
                "is_heading": 0,
                "text": "In the presence of significant proteinuria, arrange for the patient to be reviewed by the obstetric registrar/ consultant on call"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 0,
                "text": "If there are 2+ or more proteinuria on the dipstick, blood tests relating to pre- eclampsia (full blood count (FBC), clotting, liver function tests (LFT's) and LDH should be obtained and sent for analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 0,
                "text": "Arrange PCR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "text": "Obtain and send a mid stream specimen of urine for culture and sensitivity (MSU) to exclude infection"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "text": "The patient should be reviewed by the obstetric registrar/ consultant on call"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 0,
                "text": "Ultrasound: growth/ liquor/ umbilical artery Doppler, abnormal blood tests and /or Doppler or significant proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 202,
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Diastolic BP 90-109 mmHg:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 0,
                "text": "Blood tests relating to pre-eclampsia (Refer to point 5.2)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 0,
                "text": "Cardiotocograph (CTG) monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 205,
            "data": {
                "is_heading": 0,
                "text": "Ultrasound growth and liquor if concern with growth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 206,
            "data": {
                "is_heading": 0,
                "text": "Arrange an appointment to attend DAU as an outpatient"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 207,
            "data": {
                "is_heading": 0,
                "text": "Abnormal blood test and/ or Doppler results arrange an obstetric review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 0,
                "text": "Normal blood tests and Doppler results allocate patient to a named obstetric consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 0,
                "text": "Monitor at least weekly from DAU, do not routinely repeat blood tests"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 210,
            "data": {
                "is_heading": 0,
                "prefix": 90.0,
                "text": "Diastolic BP  \u2013 109 mmHg and 1+ proteinuria:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 211,
            "data": {
                "is_heading": 0,
                "text": "24 hour urine collection as an out-patient (if no maternal symptoms or clinical suspicion of fetal compromise)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 212,
            "data": {
                "is_heading": 0,
                "text": "Blood tests relating to pre-eclampsia, the patient should wait for the result"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 213,
            "data": {
                "is_heading": 0,
                "text": "Perform a CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 214,
            "data": {
                "is_heading": 0,
                "text": "Ultrasound for growth and liquor"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 215,
            "data": {
                "is_heading": 0,
                "text": "Attend DAU as an outpatient"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 216,
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "Diastolic BP 90-109 mmHg and new proteinuria \u2265 2+ on dipstick:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 217,
            "data": {
                "is_heading": 0,
                "text": "24 hour urine collection as out-patient (if no maternal symptoms or clinical suspicion of fetal compromise)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 218,
            "data": {
                "is_heading": 0,
                "text": "The patient should be admitted and reviewed by the obstetric registrar or consultant on call"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 219,
            "data": {
                "is_heading": 0,
                "text": "Blood tests relating to pre-eclampsia (Refer to point 5.2)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 220,
            "data": {
                "is_heading": 1,
                "text": "Perform a CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 221,
            "data": {
                "is_heading": 0,
                "text": "Ultrasoundgrowth/ liquor/Umbilical artery Doppler should be considered following Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 222,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Role of the DAU Midwife in Relation to Hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 223,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix A)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 224,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Diastolic BP \u2265 110 mmHg or Systolic BP \u2265 160 mmHg:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 225,
            "data": {
                "is_heading": 0,
                "text": "The patient should be admitted to labour ward and reviewed by the obstetric registrar/ consultant on call"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 226,
            "data": {
                "is_heading": 0,
                "text": "Blood tests should be obtained relating to pre-eclampsia i.e. full blood count, urea and electrolytes, uric acid and clotting studies (consider cannulation). PCR should be performed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 227,
            "data": {
                "is_heading": 0,
                "text": "A cardiotocograph (CTG) should be performed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 228,
            "data": {
                "is_heading": 0,
                "text": "Umbilical artery Doppler's should be considered following assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 229,
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Diastolic BP \u2265 110 mmHg with new proteinuria of 1+:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 230,
            "data": {
                "is_heading": 0,
                "text": "The patient should be admitted to labour ward and reviewed by the obstetric registrar/ consultant on call"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 231,
            "data": {
                "is_heading": 0,
                "text": "24 hour urinary collection"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 232,
            "data": {
                "is_heading": 0,
                "text": "Blood test relating to pre-eclampsia (consider cannulation)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 233,
            "data": {
                "is_heading": 0,
                "text": "Perform a CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 234,
            "data": {
                "is_heading": 0,
                "text": "Ultrasound growth/ liquor/ umbilical artery Doppler"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 235,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Blood Tests Relating to Pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 236,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "The blood tests relating to pre-eclampsia are as follows:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 237,
            "data": {
                "is_heading": 0,
                "text": "Platelet count"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 238,
            "data": {
                "is_heading": 0,
                "text": "Transaminases -AST"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 239,
            "data": {
                "is_heading": 0,
                "text": "Serum urate and serum creatinine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 240,
            "data": {
                "is_heading": 0,
                "text": "(Serum urate is not required if there is no proteinuria)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 241,
            "data": {
                "is_heading": 0,
                "text": "Full blood count"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 242,
            "data": {
                "is_heading": 0,
                "text": "LDH (lactate dehydrogenase) > 600 U/L (signifies haemolysis and/or infarction)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 243,
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Use pregnancy-specific normal ranges for platelets, transaminases and creatinine;  gestational age dependent ranges for serum urate as shown below:"
            }
        },
        {
            "type": "table",
            "sequence_num": 244,
            "data": {
                "num_rows": 8,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "AST"
                    },
                    {
                        "text": "ALT"
                    },
                    {
                        "text": "Non \u2013pregnant"
                    },
                    {
                        "text": "7 - 40"
                    },
                    {
                        "text": "0 - 40"
                    },
                    {
                        "text": "st1 trimester"
                    },
                    {
                        "text": "10 - 28"
                    },
                    {
                        "text": "6 - 32"
                    },
                    {
                        "text": "nd2 Trimester"
                    },
                    {
                        "text": "11 - 29"
                    },
                    {
                        "text": "6 - 32"
                    },
                    {
                        "text": "rd3 Trimester"
                    },
                    {
                        "text": "11 - 30"
                    },
                    {
                        "text": "6 - 32"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Platelet count"
                    },
                    {
                        "text": "<150x10 9/L"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Creatinine"
                    },
                    {
                        "text": ">90microgmol/L"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 245,
            "data": {
                "is_heading": 0,
                "prefix": 17.3,
                "text": "Liver function tests: gestation specific 95% reference ranges (2.5th centile \u2013 97.5th centile) in normal population."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 246,
            "data": {
                "is_heading": 0,
                "prefix": 17.4,
                "text": "It is imperative that the DAU midwife follows up all results within 24 hours of the blood sample being obtained by accessing the results/sample diary."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 247,
            "data": {
                "is_heading": 0,
                "prefix": 17.5,
                "text": "Laboratory test results should be available within no more than 24 hours of the patient attending and the same day where practically possible, with a mechanism to review the tests and talk to the patient concerned within those 24 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 248,
            "data": {
                "is_heading": 0,
                "prefix": 17.6,
                "text": "If any of the blood tests results are outside the normal range, the obstetric registrar/ consultant on call should review the results. The DAU midwife should contact the patient concerned to discuss the results with the revised antenatal care plan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 249,
            "data": {
                "is_heading": 0,
                "prefix": 17.7,
                "text": "If the blood tests are within the normal range, contact the pregnant patient and arrange/ confirm appointment in DAU to repeat assessments in one week"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 250,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Laboratory Tests for Proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 251,
            "data": {
                "is_heading": 1,
                "prefix": 18.1,
                "text": "The DAU midwife should test the urine to exclude or confirm significant proteinuria in patients with 1+ dipstick proteinuria. If there is a trace of proteinuria apparent from the Day Assessment Unit sample and 1+ of proteinuria from the community sample; use the community result. Greater than or equal to one plus of protein requires further investigations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 252,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "A  hour urine collection of \u2265 300mg in  hours both confirms and quantifies proteinuria. It is not necessary to repeat this once proteinuria has been confirmed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 253,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "In addition, a protein creatinine ratio (PCR) can be analysed by the MEHT laboratory technicians which is an instant assessment of protein; but the  hour urine collection remains the gold standard for the quantitative proteinuria. For example:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 254,
            "data": {
                "is_heading": 0,
                "text": "PCR < 30mg/mmol excludes significant proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 255,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "PCR > 30mg/mmol does not reliably quantify proteinuria, so a  hour urine collection may be required"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 256,
            "data": {
                "is_heading": 0,
                "prefix": 18.4,
                "text": "For patients with new hypertension between 90-109mmHg diastolic and 1+ proteinuria in this guideline the decision to admit should been deferred until the results of the urinary proteins are known. This is appropriate only when there are no maternal symptoms or clinical suspicion of fetal compromise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 257,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Umbilical Artery Doppler"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 258,
            "data": {
                "is_heading": 1,
                "prefix": 19.1,
                "text": "The Pre-eclampsia Community Guideline (PRECOG) group recommend umbilical artery Doppler as the best test for predicting an at-risk fetus relating to pre-eclampsia in a patient with pre-term new hypertension and no clinical suspicion of fetal compromise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 259,
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "Abnormal umbilical artery Doppler thresholds include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 260,
            "data": {
                "is_heading": 0,
                "text": "Umbilical artery PI > 2SD"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 261,
            "data": {
                "is_heading": 0,
                "text": "Absent or reverse end diastolic flow"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 262,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "DAU Obstetric Review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 263,
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "An obstetric review should be arranged within the Day Unit attended by the obstetric registrar/ consultant on call for the following patients in line with this guideline:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 264,
            "data": {
                "is_heading": 0,
                "text": "If a patient has an abnormal blood test result"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 265,
            "data": {
                "is_heading": 0,
                "text": "An abnormal Doppler"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 266,
            "data": {
                "is_heading": 0,
                "text": "Patients with new hypertension (90-109mmHg diastolic or 140 -159mmHg systolic) without proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 267,
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "Following review of the patient the obstetric registrar/ consultant on call should amend the patient's individual antenatal care plan, documented in the patient's healthcare"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 268,
            "data": {
                "is_heading": 0,
                "text": "records."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 269,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Allocation to a Named Consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 270,
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "All patients who reach the threshold for a midwifery assessment in DAU, (Diastolic >90mmHg) are at higher risk of pre-eclampsia and poor outcomes associated with the diagnosis. The DAU midwife should ensure that all patients who have had midwifery assessment have been allocated to a named obstetric consultant before they leave the DAU (with the exception to the patients who after a midwife assessment in DAU have no hypertension, no proteinuria, no relevant symptoms and a healthy baby)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 271,
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "The named obstetric consultant will either directly or indirectly determine subsequent management which should recorded in the patient's plan of care, documented in the healthcare records."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 272,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Follow-up Monitoring on the Day Assessment Unit and Community Setting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 273,
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "The DAU midwife should arrange a subsequent assessment no longer than 7 days (minimum standard) after the initial assessment and sooner if appropriate. Frequency of assessments should be determined on an individual basis, depending on blood test/ Doppler results, gestational age, history and following an antenatal care plan determined by the named consultant in consultation with the pregnant patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 274,
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "For patients with new hypertension of 90-109 mmHg without proteinuria with no"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 275,
            "data": {
                "is_heading": 0,
                "text": "relevant symptoms, a normal umbilical artery Doppler and blood tests that are within the normal range at the first assessment; this assessment should be repeated in one"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 276,
            "data": {
                "is_heading": 0,
                "text": "week."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 277,
            "data": {
                "is_heading": 0,
                "prefix": 22.3,
                "text": "If there is no change in signs or symptoms, do not routinely repeat the blood tests. A review by the obstetric registrar/ consultant on call may be appropriate if the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 278,
            "data": {
                "is_heading": 0,
                "text": "hypertension is persistent. Progression, as shown by changing blood parameters,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 279,
            "data": {
                "is_heading": 0,
                "text": "emerging symptomatology or change in signs will require reviewed by the obstetric registrar/ consultant on call review resulting in a possible admission episode."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 280,
            "data": {
                "is_heading": 0,
                "prefix": 22.4,
                "text": "Arrange for the patient to be assessed in the community within a maximum of 7 days of leaving the Day Assessment Unit if she has no hypertension, no new or significant proteinuria, no symptoms and there is no suspicion of fetal compromise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 281,
            "data": {
                "is_heading": 0,
                "prefix": 22.5,
                "text": "In the subsequent plan of care there should be an interval of no more than 2 weeks between assessments; these patients are no longer within the NICE guideline recommendations for routine antenatal care and all are at higher risk of developing pre- eclampsia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 282,
            "data": {
                "is_heading": 0,
                "prefix": 22.6,
                "text": "Some patients will have had transient signs/ symptoms that will recur. Offer a DAU assessment to detect and act on any signs and symptoms."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 283,
            "data": {
                "is_heading": 0,
                "prefix": 22.7,
                "text": "Before a patient leaves her initial DAU assessment she should have the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 284,
            "data": {
                "is_heading": 0,
                "text": "Information to understand the signs and symptoms of fulminating pre-eclampsia, the rate at which it may develop and the potential seriousness of her situation to include the hypertension and pre-eclampsia patient information leaflet"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 285,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix B)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 286,
            "data": {
                "is_heading": 0,
                "text": "A mechanism to report and act on any new symptoms that she may notice herself; encourage her to self monitor"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 287,
            "data": {
                "is_heading": 0,
                "text": "Patient handheld records or a DAU summary from her assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 288,
            "data": {
                "is_heading": 0,
                "text": "A follow-up appointment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 289,
            "data": {
                "is_heading": 0,
                "text": "Allocation to a named obstetric consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 290,
            "data": {
                "is_heading": 0,
                "text": "Agreed mechanisms by which the patient will be informed of her test results and discuss any change to her antenatal care plan within 24 hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 291,
            "data": {
                "is_heading": 0,
                "text": "An understanding that she can be proactive in following up any results and arranging a follow up appointment if the contact arrangements do not work"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 292,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Staffing and Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 293,
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "All midwifery and obstetric staff must attend yearly mandatory training which includes skills and drills training."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 294,
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "All midwifery and obstetric staff are to ensure that their knowledge and skills are up-to-date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 295,
            "data": {
                "is_heading": 1,
                "prefix": 22.3,
                "text": "Guideline Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 296,
            "data": {
                "is_heading": 0,
                "text": "23.3.1 As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 297,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Professional Midwifery Advocates"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 298,
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "Professional Midwifery Advocates provide a mechanism of support and guidance to women and midwives. Professional Midwifery Advocates are experienced practising midwives who have undertaken further education in order to supervise midwifery services and to advise and support midwives and women in their care choices."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 299,
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 300,
            "data": {
                "is_heading": 0,
                "prefix": 25.1,
                "text": "All staff should follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 301,
            "data": {
                "is_heading": 0,
                "prefix": 25.2,
                "text": "All staff should ensure that they follow Trust guidelines on infection prevention. All invasive devices must be inserted and cared for using High Impact Intervention guidelines to reduce the risk of infection and deliver safe care. This care should be recorded in the Saving Lives High Impact Intervention Monitoring Tool Paperwork (Medical Devices)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 302,
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 303,
            "data": {
                "is_heading": 0,
                "prefix": 26.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy and Policy (register number 08076), the Corporate Clinical Audit and Quality Improvement Project Plan and the Maternity annual audit work plan; to encompass national and local audit and clinical governance identifying key harm themes. The Women's and Children's Clinical Audit Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 304,
            "data": {
                "is_heading": 0,
                "prefix": 26.2,
                "text": "The findings of the audit will be reported to and approved by the Multi-disciplinary Risk Management Group (MRMG) and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 305,
            "data": {
                "is_heading": 0,
                "prefix": 26.3,
                "text": "The audit report will be reported to the monthly Directorate Governance Meeting (DGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 306,
            "data": {
                "is_heading": 0,
                "prefix": 26.4,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Safety Group within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 307,
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Approval and Implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 308,
            "data": {
                "is_heading": 0,
                "prefix": 27.1,
                "text": "All policies, procedures and guidelines will be approved locally by the Maternity and Gynaecology Practice Steering Group prior to submission to the Controlled Document team for ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 309,
            "data": {
                "is_heading": 0,
                "prefix": 27.2,
                "text": "It is the Guidelines and Audit Nurse's and author's responsibility to inform the Maternity and Gynaecology Practice Steering Group and appropriate Maternity Services' staff of the approved policy documents when they are uploaded to the Trust's Intranet."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 310,
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 311,
            "data": {
                "is_heading": 0,
                "text": "National Institute for Clinical Excellence (2019). Management of pre-eclampsia IN Hypertension in pregnancy: diagnosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 312,
            "data": {
                "is_heading": 1,
                "text": "and management. NICE Guideline (NG133) London: NICE."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 313,
            "data": {
                "is_heading": 0,
                "text": "https://www.nice.org.uk/guidance/ng133/chapter/Recommendations#management-of-pre-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 314,
            "data": {
                "is_heading": 1,
                "text": "eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 315,
            "data": {
                "is_heading": 0,
                "text": "PRECOG Development Group (2009) Pre-eclampsia day assessment unit guideline for midwives. Recommendations 9 and 10. PRECOG 2 (DAU) http://action-on-pre-eclampsia.org.uk/wp-content/uploads/2012/07/PRECOG-Day- Assessment.pdf"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 316,
            "data": {
                "is_heading": 0,
                "text": "Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothers' Care - Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2016."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 317,
            "data": {
                "is_heading": 0,
                "text": "Magpie Trial Follow-Up Study Collaborative Group, (2007). The Magpie trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia outcome for women at 2 years. British Journal of Obstetrics and Gynaecology, 114(3), pp300-399. Available at: www.obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/j.1471- 0528.2006.01166.x"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 318,
            "data": {
                "is_heading": 1,
                "text": "Appendix A"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 319,
            "data": {
                "is_heading": 1,
                "text": "Hypertension/ Pre-Eclampsia Flowchart"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 320,
            "data": {
                "is_heading": 1,
                "text": "Care in Day Assessment Unit"
            }
        },
        {
            "type": "image",
            "sequence_num": 321,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.003.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 322,
            "data": {
                "is_heading": 1,
                "text": "Carry out full assessment in Day Assessment Unit"
            }
        },
        {
            "type": "image",
            "sequence_num": 323,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.004.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 324,
            "data": {
                "is_heading": 0,
                "text": "A healthcare professional trained in the management of hypertensive disorders should carry out the assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 325,
            "data": {
                "is_heading": 0,
                "text": "Take into account previous history of pre-eclampsia or gestational hypertension, pre-existing vascular or kidney disease, moderate risk factors for pre-eclampsia and gestational age at presentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 326,
            "data": {
                "is_heading": 1,
                "text": "Hypertension  Severe hypertension (BP 140/90\u2013159/109mmHg)Clinical assessment  (BP \u2265 160/110 mmHg) for maternal symptoms"
            }
        },
        {
            "type": "image",
            "sequence_num": 327,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.005.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 328,
            "data": {
                "is_heading": 0,
                "text": "Following hypertension Clinical assessment of fetal size and wellbeing,  criteria, with the addition consider ultrasound for growth and liquor  of-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 329,
            "data": {
                "is_heading": 0,
                "text": "volume. Consider Umbilical artery Dopplers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 330,
            "data": {
                "is_heading": 0,
                "text": "Admit to Labour ward"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 331,
            "data": {
                "is_heading": 0,
                "text": "Dipstick test for proteinuria, if 1+> consider 24"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 332,
            "data": {
                "is_heading": 0,
                "text": "hour collection  Consider cannulation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 333,
            "data": {
                "is_heading": 0,
                "text": "when obtaining blood Serial BP- 3x 15 minute intervals  samples"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 334,
            "data": {
                "is_heading": 0,
                "text": "Blood tests relating to Pre eclampsia. Arrange an obstetric reviewConsider first line oral Labetalol"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 335,
            "data": {
                "is_heading": 0,
                "text": "Consider corticosteroids if less than 36+6 weeks  Yes gestation  No"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 336,
            "data": {
                "is_heading": 0,
                "text": "Refer to care in labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 337,
            "data": {
                "is_heading": 1,
                "text": "Timing of birth"
            }
        },
        {
            "type": "image",
            "sequence_num": 338,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.007.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 339,
            "data": {
                "is_heading": 0,
                "text": "In-patients receiving Before 34 weeks gestation  outpatient care after"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 340,
            "data": {
                "is_heading": 0,
                "text": "severe hypertension has Manage conservatively, make plan of care, offer steroids,  been effectively"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 341,
            "data": {
                "is_heading": 0,
                "text": "offer birth if maternal, clinical indications develop.  controlled in hospital: 34-36 weeks gestation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 342,
            "data": {
                "is_heading": 0,
                "text": "Measure BP and test Offer birth if Pre Eclampsia with mild or moderate  for proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 343,
            "data": {
                "is_heading": 0,
                "text": "hypertension depending on maternal and fetal condition,  twice a week"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 344,
            "data": {
                "is_heading": 0,
                "text": "risk factors and availability of neonatal intensive care"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 345,
            "data": {
                "is_heading": 0,
                "text": "Carry out blood tests After 37 weeks gestation recommend birth within 24 -48  weekly"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 346,
            "data": {
                "is_heading": 0,
                "text": "hours, if pre-eclampsia with mild or moderate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 347,
            "data": {
                "is_heading": 0,
                "text": "hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 348,
            "data": {
                "is_heading": 0,
                "text": "Pre-eclampsia and hypertension on DAU / 11006 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 349,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 350,
            "data": {
                "is_heading": 1,
                "text": "RECOMMENDATION 10: FLOWCHART 1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 351,
            "data": {
                "is_heading": 0,
                "text": "New proteinuria without hypertension; no suspicion of fetal compromise or symptoms"
            }
        },
        {
            "type": "image",
            "sequence_num": 352,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.008.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 353,
            "data": {
                "is_heading": 0,
                "text": "1+ proteinuria on dipstick  2+ proteinuria or more on dipstick"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 354,
            "data": {
                "is_heading": 0,
                "text": "Blood tests for pre-eclampsia;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 355,
            "data": {
                "is_heading": 0,
                "text": "24 hour urine collection  24 hour urine collection  Oxford Sonicare CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 356,
            "data": {
                "is_heading": 0,
                "text": "Normal blood test and  Abnormal blood and/or Significant proteinuria  No significant proteinuria  CTG; no significant  CTGor significant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 357,
            "data": {
                "is_heading": 0,
                "text": "proteinuria  proteinuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 358,
            "data": {
                "is_heading": 0,
                "text": "Arrange medical review  Community assessment  Allocate to named consultant;  Arrange medical review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 359,
            "data": {
                "is_heading": 0,
                "text": "within 1 week  monitor at least weekly"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 360,
            "data": {
                "is_heading": 1,
                "text": "RECOMMENDATION 10: FLOWCHART 2"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 361,
            "data": {
                "is_heading": 0,
                "text": "New hypertension and new proteinuria; no suspicion of fetal compromise or symptoms"
            }
        },
        {
            "type": "image",
            "sequence_num": 362,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.009.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 363,
            "data": {
                "is_heading": 0,
                "text": "Diastolic BP \uf0b3  Diastolic Bp 90- Diastolic BP \uf0b3  Diastolic BP 90-109mmHg and 1+ 110mmHg and new  109mmHg and new  90mmHg and new  proteinuria (use higher of community or proteinuria of 1+  proteinuria of 1+  proteinuria 2+ or more  DAU results)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 364,
            "data": {
                "is_heading": 1,
                "text": "Arrange medical  ADMIT  24 hour urine collection as"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 365,
            "data": {
                "is_heading": 1,
                "text": "review to consider  outpatient; blood tests for  Oxford Sonicare ADMIT  admission  pre-eclampsia  CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 366,
            "data": {
                "is_heading": 0,
                "text": "No significant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 367,
            "data": {
                "is_heading": 0,
                "text": "proteinuria, normal"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 368,
            "data": {
                "is_heading": 0,
                "text": "blood test and Doppler  Significant proteinuria  Abnormal blood results  and/or CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 369,
            "data": {
                "is_heading": 1,
                "text": "Arrange medical ADMIT  review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 370,
            "data": {
                "is_heading": 0,
                "text": "Allocate to named consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 371,
            "data": {
                "is_heading": 0,
                "text": "Monitor at least weekly"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 372,
            "data": {
                "is_heading": 1,
                "text": "RECOMMENDATION 10: FLOWCHART 3"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 373,
            "data": {
                "is_heading": 0,
                "text": "New hypertension without proteinuria; no clinical suspicion of fetal compromise and no symptoms"
            }
        },
        {
            "type": "image",
            "sequence_num": 374,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.010.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 375,
            "data": {
                "is_heading": 0,
                "text": "Diastolic BP \uf0b3110mmHg or  Diastolic BP 100-109mmHg or  Diastolic BP 90-99mmHg Systolic BP \uf0b3 170mmHg  Systolic BP 160-169mmHg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 376,
            "data": {
                "is_heading": 0,
                "text": "Blood tests for pre-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 377,
            "data": {
                "is_heading": 1,
                "text": "eclampsia.  CTG ADMIT  Arrange medical review to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 378,
            "data": {
                "is_heading": 0,
                "text": "consider admission"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 379,
            "data": {
                "is_heading": 0,
                "text": "CTGand blood test results Abnormal CTGand/or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 380,
            "data": {
                "is_heading": 0,
                "text": "blood test results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 381,
            "data": {
                "is_heading": 0,
                "text": "Allocate to named consultant; Arrange medical review  Monitor at least weekly. Do not"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 382,
            "data": {
                "is_heading": 0,
                "text": "routinely repeat blood tests"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 383,
            "data": {
                "is_heading": 0,
                "text": "Pre-eclampsia and hypertension on DAU / 11006 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 384,
            "data": {
                "is_heading": 1,
                "text": "Key: PCR: Urinary protein creatinine ratio Blood tests for pre-eclampsia: platelet count; AST or ALT; serum creatinine; serum urate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 385,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Guideline: precog DAU/ recommendation  flowcharts"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 386,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 387,
            "data": {
                "is_heading": 1,
                "text": "Appendix B"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 388,
            "data": {
                "is_heading": 1,
                "text": "Antenatal Pharmacological Management"
            }
        },
        {
            "type": "table",
            "sequence_num": 389,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Drugs for the treatment of hypertension in pregnancy"
                    },
                    {
                        "text": "AGENTS"
                    },
                    {
                        "text": "DOSE"
                    },
                    {
                        "text": "COMMENTS"
                    },
                    {
                        "text": "Labetalol"
                    },
                    {
                        "text": "200 mg bd \u2013 600 mg qds"
                    },
                    {
                        "text": "Contraindicated in moderate-severe asthma. May be associated with neonatal bradycardia First line therapy"
                    },
                    {
                        "text": "Methyldopa"
                    },
                    {
                        "text": "250 mg bd \u2013 1g tds"
                    },
                    {
                        "text": "May cause lethargy and dizziness, rarely depression and deranged liver function tests First line therapy"
                    },
                    {
                        "text": "Nifedipine"
                    },
                    {
                        "text": "10 \u2013 40 mg SR bd"
                    },
                    {
                        "text": "Possible interference with labour. Hypotension reported with concominant use of magnesium sulphate in preeclampsia. May cause headache, flushing and peripheral oedema First line therapy"
                    },
                    {
                        "text": "Hydralazine"
                    },
                    {
                        "text": "25 \u2013 75mg tds"
                    },
                    {
                        "text": "Second / Third line therapy"
                    },
                    {
                        "text": "Amlodipine"
                    },
                    {
                        "text": "5-10mg od"
                    },
                    {
                        "text": "Third line therapy if nifedipine not tolerated or poor concordance with bd / tds therapy"
                    },
                    {
                        "text": "Doxazocin"
                    },
                    {
                        "text": "1mg od \u2013 8 mg bd"
                    },
                    {
                        "text": "Third line therapy"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 390,
            "data": {
                "is_heading": 1,
                "text": "Appendix C"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 391,
            "data": {
                "is_heading": 1,
                "text": "Appendix D"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 392,
            "data": {
                "is_heading": 1,
                "text": "Management of Hypertension"
            }
        },
        {
            "type": "image",
            "sequence_num": 393,
            "data": {
                "url": "11006 Antenatal management of pre-eclampsia and hypertension 4.0.011.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 394,
            "data": {
                "is_heading": 0,
                "text": "Pre-eclampsia and hypertension on DAU / 11006 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 395,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 396,
            "data": {
                "is_heading": 0,
                "text": "Pre-eclampsia and hypertension on DAU / 11006 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 397,
            "data": {
                "is_heading": 1,
                "text": "Appendix E: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 398,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Pre-eclampsia and hypertension on DAU / 11006 (please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 399,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "X A change to an existing policy"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new policy"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 400,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full review"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 yearly review to keep in line with change to NICE recommendations"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients; reduced risk due to monitoring and treatment in line with NICE guidelines"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 401,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "14 August 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 402,
            "data": {
                "is_heading": 1,
                "text": "."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 403,
            "data": {
                "is_heading": 0,
                "prefix": 29.0,
                "text": ""
            }
        }
    ]
}